In pituitary tumors, it has been reported that E2F1 affects PTTG1 expression [47]. Moreover, microarray analyses identified securin and several other mitotic checkpoint proteins, such as Bub1, Bub3 and Cdc20, as putative E2F1 targets [48]. This evidence concerns the gene BUB1 and pituitary tumor.